The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The Exopolysaccharide Alginate Protects Pseudomonas aeruginosa Biofilm Bacteria from IFN-γ-Mediated Macrophage Killing
Abstract
The ability of Pseudomonas aeruginosa to form biofilms and cause chronic infections in the lungs of cystic fibrosis patients is well documented. Numerous studies have revealed that P. aeruginosa biofilms are highly refractory to antibiotics. However, dramatically fewer studies have addressed P. aeruginosa biofilm resistance to the host’s immune system. In planktonic, unattached (nonbiofilm) P. aeruginosa, the exopolysaccharide alginate provides protection against a variety of host factors yet the role of alginate in protection of biofilm bacteria is unclear. To address this issue, we tested wild-type strains PAO1, PA14, the mucoid cystic fibrosis isolate, FRD1 (mucA22+), and the respective isogenic mutants which lacked the ability to produce alginate, for their susceptibility to human leukocytes in the presence and absence of IFN-γ. Human leukocytes, in the presence of recombinant human IFN-γ, killed biofilm bacteria lacking alginate after a 4-h challenge at 37°C. Bacterial killing was dependent on the presence of IFN-γ. Killing of the alginate-negative biofilm bacteria was mediated through mononuclear cell phagocytosis since treatment with cytochalasin B, which prevents actin polymerization, inhibited leukocyte-specific bacterial killing. By direct microscopic observation, phagocytosis of alginate-negative biofilm bacteria was significantly increased in the presence of IFN-γ vs all other treatments. Addition of exogenous, purified alginate to the alginate-negative biofilms restored resistance to human leukocyte killing. Our results suggest that although alginate may not play a significant role in bacterial attachment, biofilm development, and formation, it may play an important role in protecting mucoid P. aeruginosa biofilm bacteria from the human immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P. aeruginosa produces three main exopolysaccharides (EPS): alginate, Pel, and Psl, which form the extracellular matrix in the biofilm and have a structural and protective function (Leid et al., 2005; Ryder et al., 2007; Colvin et al., 2011, 2012).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Leid et al., 2005
In the citing paper
“The switch to a mucoid phenotype contributes to the establishment of chronic colonization since alginate offers structural protection against uptake by macrophages and antimicrobials by forming a barrier limiting the penetration of antimicrobials, macrophages and macrophage-derived products, such as the pro-phagocytic cytokine IFN-γ (Leid et al., 2005; Ryder et al., 2007).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Leid et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00797.x · Cited by 2,537
Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M., & Beachey, E. H. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.996-1006.1985 · Cited by 2,255
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Self-citation
Cited by
Evolving concepts in biofilm infections
Hall-Stoodley, L., & Stoodley, P. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01323.x · Cited by 1,136
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Kostakioti, M., Hadjifrangiskou, M., & Hultgren, S. J. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010306 · Cited by 999
Bacterial Extracellular Polysaccharides in Biofilm Formation and Function
Limoli, D. H., Jones, C. J., & Wozniak, D. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0011-2014 · Cited by 924
Bjarnsholt, T., Alhede, M., Alhede, M., Eickhardt-Sørensen, S. R., Moser, C., Kühl, M., Jensen, P. Ø., & Høiby, N. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.002 · Cited by 764
Biofilm Formation Mechanisms and Targets for Developing Antibiofilm Agents
Rabin, N., Zheng, Y., Opoku-Temeng, C., Du, Y., Bonsu, E., & Sintim, H. O. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.6 · Cited by 753
Bryers, J. D. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21838 · Cited by 700
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063128 · Cited by 698
Malone, M., Bjarnsholt, T., McBain, A. J., James, G. A., Stoodley, P., Leaper, D., Tachi, M., Schultz, G., Swanson, T., & Wolcott, R. D. (2017) · Journal of Wound Care · doi:10.12968/jowc.2017.26.1.20 · Cited by 663
Pseudomonas biofilm matrix composition and niche biology
Mann, E. E., & Wozniak, D. J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00322.x · Cited by 606
Role of polysaccharides in Pseudomonas aeruginosa biofilm development
Ryder, C., Byrd, M., & Wozniak, D. J. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.09.010 · Cited by 580
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Rossi, E., La Rosa, R., Bartell, J. A., Marvig, R. L., Haagensen, J. A. J., Sommer, L. M., Molin, S., & Johansen, H. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00477-5 · Cited by 525
Pseudomonas aeruginosa Biofilms in Disease
Mulcahy, L. R., Isabella, V. M., & Lewis, K. (2014) · Microbial Ecology · doi:10.1007/s00248-013-0297-x · Cited by 518
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
ATP-Dependent Persister Formation in Escherichia coli
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017) · mBio · doi:10.1128/mbio.02267-16 · Cited by 508
Biofilm-Specific Antibiotic Resistance
Mah, T.-F. (2012) · Future Microbiology · doi:10.2217/fmb.12.76 · Cited by 504
Biofilms in Chronic Wounds: Pathogenesis and Diagnosis
Wu, Y.-K., Cheng, N.-C., & Cheng, C.-M. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.10.011 · Cited by 473
Bacterial Contribution in Chronicity of Wounds
Rahim, K., Saleha, S., Zhu, X., Huo, L., Basit, A., & Franco, O. L. (2017) · Microbial Ecology · doi:10.1007/s00248-016-0867-9 · Cited by 443
Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window
Wolcott, R. D., Rumbaugh, K. P., James, G., Schultz, G., Phillips, P., Yang, Q., Watters, C., Stewart, P. S., & Dowd, S. E. (2010) · Journal of Wound Care · doi:10.12968/jowc.2010.19.8.77709 · Cited by 423
Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review
Tuon, F. F., Dantas, L. R., Suss, P. H., & Tasca Ribeiro, V. S. (2022) · Pathogens · doi:10.3390/pathogens11030300 · Cited by 422
Biofilms and chronic wound inflammation
Wolcott, R. D., Rhoads, D. D., & Dowd, S. E. (2008) · Journal of Wound Care · doi:10.12968/jowc.2008.17.8.30796 · Cited by 417
Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing
Wolcott, R. D., Hanson, J. D., Rees, E. J., Koenig, L. D., Phillips, C. D., Wolcott, R. A., Cox, S. B., & White, J. S. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12370 · Cited by 414
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Maurice, N. M., Bedi, B., & Sadikot, R. T. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0321tr · Cited by 373
Bacterial alginates: from biosynthesis to applications
Remminghorst, U., & Rehm, B. H. A. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9156-x · Cited by 373
Biofilm Matrix and Its Regulation in Pseudomonas aeruginosa
Wei, Q., & Ma, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020983 · Cited by 369
Biofilms: Survival and defense strategy for pathogens
Kumar, A., Alam, A., Rani, M., Ehtesham, N. Z., & Hasnain, S. E. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.09.016 · Cited by 368
Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments
Singh, S., Datta, S., Narayanan, K. B., & Rajnish, K. N. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00242-y · Cited by 331
Action of Antimicrobial Peptides against Bacterial Biofilms
Yasir, M., Willcox, M. D. P., & Dutta, D. (2018) · Materials · doi:10.3390/ma11122468 · Cited by 319
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Chatterjee, M., Anju, C. P., Biswas, L., Anil Kumar, V., Gopi Mohan, C., & Biswas, R. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.11.004 · Cited by 312
Chronic wounds and the medical biofilm paradigm
Wolcott, R. D., Rhoads, D. D., Bennett, M. E., Wolcott, B. M., Gogokhia, L., Costerton, J. W., & Dowd, S. E. (2010) · Journal of Wound Care · doi:10.12968/jowc.2010.19.2.46966 · Cited by 306
The polymicrobial nature of biofilm infection
Wolcott, R., Costerton, J. W., Raoult, D., & Cutler, S. J. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.04001.x · Cited by 298
In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.
Hotterbeekx, A., Kumar-Singh, S., Goossens, H., & Malhotra-Kumar, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00106 · Cited by 289
P. aeruginosa Biofilms in CF Infection
Wagner, V. E., & Iglewski, B. H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8079-9 · Cited by 288
Schulze, A., Mitterer, F., Pombo, J. P., & Schild, S. (2021) · Microbial Cell · doi:10.15698/mic2021.02.741 · Cited by 275
Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Barraud, N., Kelso, M., Rice, S., & Kjelleberg, S. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140905112822 · Cited by 255
Gunn, J. S., Bakaletz, L. O., & Wozniak, D. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.707547 · Cited by 211
Microbial interactions in building of communities
Wright, C. J., Burns, L. H., Jack, A. A., Back, C. R., Dutton, L. C., Nobbs, A. H., Lamont, R. J., & Jenkinson, H. F. (2013) · Molecular Oral Microbiology · doi:10.1111/omi.12012 · Cited by 185
“Biofilms are also more resilient to mechanical removal and to killing by the host immune system (Leid et al., 2005).”
BackgroundMalic, S., Hill, K. E., Hayes, A., Percival, S. L., Thomas, D. W., & Williams, D. W. (2009) · Microbiology · doi:10.1099/mic.0.028712-0 · Cited by 182
Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
Jiang, P., Li, J., Han, F., Duan, G., Lu, X., Gu, Y., & Yu, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018514 · Cited by 165
Arenas, J., Nijland, R., Rodriguez, F. J., Bosma, T. N. P., & Tommassen, J. (2013) · Molecular Microbiology · doi:10.1111/mmi.12097 · Cited by 70
“Biofilms are highly structured communities of bacteria on solid surfaces, which can confer protection against antibiotics or cellular defence systems of the host (Leid et al., 2005; Jensen et al., 2010).”
BackgroundMumm, K., Ainsaar, K., Kasvandik, S., Tenson, T., & Hõrak, R. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00420 · Cited by 19
Metadata
- Authors
- Leid, J. G., Willson, C. J., Shirtliff, M. E., Hassett, D. J., Parsek, M. R., & Jeffers, A. K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 175
- Issue
- 11
- Pages
- 7512-7518
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2163803918
- Cited by
- 525
- References
- 49
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.